Sierra Oncology's Series C Round

Sierra Oncology raised a round of funding on January 13, 2014.

Sierra Oncology, formerly ProNAi Therapeutics, is applying nucleic acid-based DNA interference technology (DNAi) to discover and develop therapeutic approaches for cancer and other diseases. The compa…

Articles about Sierra Oncology's Series C Round: